4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-23-014289
EVP Research & Development sold 7,000 shares at $40.00 ($280,000)
- EVP Research & Development acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Malik Fady Ibraham · EVP Research & Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,000 | $7.96 | $55,720 | 174,183 | D |
| 2023-05-03 | Sale : show line 2 in the form 10b5-1 | −7,000 | $40.00 | $280,000 | 167,183 | D |
| Open-market sales · 7,000 sh · avg $40.00 · $280,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −7,000 | 74,322 | D |
Loading xslF345X04/form4.xml…